News | 2020.02.27
All travelers can come into contact with health risks that are completely different from those they generally encounter on a daily basis. So it is vital to prepare thoroughly for any trip – and that involves consulting a specialist travel clinic such as the Institut Pasteur Medical Center (CMIP).Travel is a formative experience for young people – and young people often take a casual attitude to...
Document de presse | 2022.05.18
Antibiotic resistance represents a major public health challenge, associated with a high mortality rate. While bacteriophages – viruses that kill bacteria – could be a solution for fighting antibiotic-resistant pathogens, various obstacles stand in the way of their clinical development. To overcome them, researchers from Inserm, Université Sorbonne Paris Nord and Université Paris-Cité at the IAME...
Document de presse | 2023.06.02
The aim of immunotherapy strategies is to use cells in the patient's own immune system to destroy tumor cells. CAR T cell therapy is an immunotherapy that is effective in treating blood cancer. Around 35,000 people are affected by blood cancer each year in France, with 1.24 million cases worldwide. By closely investigating some of the immune cells generated during this therapy, known as CD4 T...
Document de presse | 2023.11.14
A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic. Recently reported cases have mainly been caused by...
News | 2024.07.04
Scientists have pinpointed the precise binding sites for the virus HKU1 in respiratory cells, providing a detailed picture of the infection mechanism used by the virus. Their findings shed light on other animal species that may host the virus and pave the way for the development of infection-blocking antibodies.
Article | 2023.12.18
This interdisciplinary programme, funded by ECDC, combines lectures and practical sessions delivered by multiple host institutions in order to enhance surveillance, preparedness, and readiness to respond to outbreaks.
Document de presse | 2014.01.23
A team of scientists from the Institut Pasteur, the CNRS and Paris Diderot University has identified a new regulation mechanism that enables a pathogenic bacterium of the Streptococcus genus to rapidly adapt to its host. This study was published on January 16, 2014 in PLoS Pathogens. The mechanism in question enables the bacterium to minimize its exposure to the immune system while maintaining...
Document de presse | 2013.04.16
Scientists at the Institut Pasteur, the CNRS, the Institut Curie and Inserm have identified a unique mechanism that enables the bacterial pathogen Legionella pneumophila (the causative agent of Legionnaires’ disease or legionellosis) to "reprogram" the gene expression of the eukaryotic cells that it infects. This mechanism, which has never been observed before, facilitates the...
Document de presse | 2012.10.31
Researchers at the Institut Pasteur, the CNRS, and the University of Tsukuba Faculty of Medicine (Japan) have proven for the first time that activating a specific gene in Staphylococcus aureus enables it to incorporate extracellular DNA and develop resistance to methicillin. They have also identified two mechanisms for the activation of the gene in question. These results represent an important...
Document de presse | 2012.09.26
Researchers at the Institut Pasteur and the French National Center for Scientific Research (CNRS), in collaboration with Imperial College London, have synthesized two molecules capable of quickly and irreversibly stopping the growth of P. falciparum at every blood stage of its life cycle. These molecules work by inhibiting the histone methyltransferase enzymes necessary for the parasite’s...